EDP Sciences logo
Soumettre un article
rechercher
Menu
Accueil Tous les numéros Volume 20 / Numéro 2 (March-April 2013) OCL, 20 2 (2013) 88-92 Références
Open Access
Numéro
OCL
Volume 20, Numéro 2, March-April 2013
Page(s) 88 - 92
Section Dossier : La place des lipides dans l’alimentation
DOI https://doi.org/10.1051/ocl.2012.0495
Publié en ligne 15 mars 2013
  • Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: Successive emergence of the clinical symptoms. Ann Neurol 2008 ; 64 : 492–498. [CrossRef] [PubMed] [Google Scholar]
  • Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early Type 2 diabetes. Arch Neurol 2011 ; 68 : 51–57. [CrossRef] [PubMed] [Google Scholar]
  • Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007 ; 69 : 1921–1930. [CrossRef] [PubMed] [Google Scholar]
  • Barberger-Gateau P, Samieri C, Allès B, Féart C. Could nutrition prevent the onset of dementia? Current evidence from epidemiological and intervention studies. Neurodegener Dis Manag 2012 ; 2 : 305–314. [CrossRef] [Google Scholar]
  • Barberger Gateau P. PUFAs and risk of cognitive decline or dementia: epidemiological data. OCL 2007 ; 14 : 198–201. [Google Scholar]
  • Barberger Gateau P, Feart C, Samieri C. Mediterranean diet and cognitive decline: what role for omega-3 polyunsaturated fatty acids? OCL 2011 ; 18 : 224–227. [EDP Sciences] [Google Scholar]
  • Barberger Gateau P, Samieri C, Feart C, Plourde M. Dietary omega 3 polyunsaturated fatty acids and Alzheimer’s disease: Interaction with apolipoprotein E genotype. Curr Alzheimer Res 2011 ; 8 : 479–491. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane S, Nugent S, Roy M, et al. Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 2011 ; 27 : 3–20. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 2009 ; 48 : 239–256. [CrossRef] [PubMed] [Google Scholar]
  • Dangour AD, Andreeva VA, Sydenham E, Uauy R. Omega 3 fatty acids and cognitive health in older people. Br J Nutr 2012 ; 107 (Suppl. 2) : S152-8–8. [CrossRef] [PubMed] [Google Scholar]
  • De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994 ; 343 : 1454–1459. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Alles B, Merle B, Samieri C, Barberger-Gateau P. Adherence to a Mediterranean diet and energy, macro-, and micronutrient intakes in older persons. J Physiol Biochem 2012 ; 68 : 691–700. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Jutand MA, Larrieu S, et al. Energy, macronutrient and fatty acid intake of French elderly community dwellers and association with socio-demographic characteristics : data from the Bordeaux sample of the Three-City Study. Br J Nutr 2007 ; 98 : 1046–1057. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 2010 ; 13 : 14–18. [CrossRef] [PubMed] [Google Scholar]
  • Jack JR CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010 ; 9 : 119–128. [CrossRef] [PubMed] [Google Scholar]
  • Mamelak M. Sporadic Alzheimer’s disease: the starving brain. J Alzheimers Dis 2012 ; 31 : 459–474. [CrossRef] [PubMed] [Google Scholar]
  • Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging 2012 ; 33 : 1482.e17-29. [CrossRef] [PubMed] [Google Scholar]
  • Plourde M, Vohl M-C, Vandal M, Couture P, Lemieux S, Cunnane SC. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR-alpha L162V polymorphism in men. Br J Nutr 2009 ; 102 : 1121–1124. [CrossRef] [PubMed] [Google Scholar]
  • Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010 ; 67 : 505–512. [CrossRef] [PubMed] [Google Scholar]
  • Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 2010 ; 304 : 1903–1911. [CrossRef] [PubMed] [Google Scholar]
  • Ramaroson H, Helmer C, Barberger-Gateau P, Letenneur L, Dartigues JF. Prévalence de la démence et de la maladie d’Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID. Rev Neurol 2003 ; 159 : 405–411. [Google Scholar]
  • Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001 ; 56 : 37–42. [CrossRef] [PubMed] [Google Scholar]
  • Samieri C, Maillard P, Crivello F, et al. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 2012 ; 79 : 642–650. [CrossRef] [PubMed] [Google Scholar]
  • Scheltens P, Kamphuis PJGH, Verhey FRJ, et al. Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement 2010 ; 6(1–10) : e1. [CrossRef] [Google Scholar]
  • Scheltens P, Twisk JW, Blesa R, et al. Efficacy of souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis 2012 ; 31 : 225–236. [CrossRef] [PubMed] [Google Scholar]
  • Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012 ; 6 : CD005379. [Google Scholar]
  • Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: How to move forward? Neurology 2009 ; 72 : 368–374. [CrossRef] [PubMed] [Google Scholar]
  • Yurko-Mauro K, Mccarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010 ; 6 : 456–464. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.